跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Zzzilipton Capsule - NPRA Drug Approval Details
Approvals
/
NPRA
/
Zzzilipton Capsule
Approved
STANDARD
Zzzilipton Capsule
Bioalpha International Sdn. Bhd.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Nov 28, 2025
Approval ID
0c61a45491aa0029
Company
Bioalpha International Sdn. Bhd.
Type
Standard
Approval Details
Approval Id
0c61a45491aa0029
Drug Approval Npra Name
Zzzilipton Capsule
Product Name
Zzzilipton Capsule
Registration Number
MAL19066014T
Holder Company Name
Bioalpha International Sdn. Bhd.
Holder Address
NO. 10, JALAN P/9A, SEKSYEN 13 43650 BANDAR BARU BANGI MALAYSIA
Holder Phone
03-8925 1222
Manufacturer Company Name
Bioalpha International Sdn. Bhd.
Manufacturer Address
NO. 10, JALAN P/9A, SEKSYEN 13 43650 BANDAR BARU BANGI MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL19066014T
Version
1751614227
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Nov 28, 2025
Approval ID
0c61a45491aa0029
Type
Standard
Source
Official Source
Back to NPRA Approvals